Raniclor en es it fr

Raniclor Brand names, Raniclor Analogs

Raniclor Brand Names Mixture

  • No information avaliable

Raniclor Chemical_Formula


Raniclor RX_link


Raniclor fda sheet

Raniclor FDA

Raniclor msds (material safety sheet)

Raniclor MSDS

Raniclor Synthesis Reference

R. R. Chauvette, U.S. Pat. 3,925,372 (1975)

Raniclor Molecular Weight

367.808 g/mol

Raniclor Melting Point

327 oC

Raniclor H2O Solubility

8.6 mg/mL

Raniclor State


Raniclor LogP


Raniclor Dosage Forms

Capsule; Powder; Powder for solution; Powder for suspension; Suspension

Raniclor Indication

For the treatment of certain infections caused by bacteria such as pneumonia and ear, lung, skin, throat, and urinary tract infections.

Raniclor Pharmacology

Cefaclor is a second generation cephalosporin antibiotic with a spectrum resembling first-generation cephalosporins. In vitro tests demonstrate that the bactericidal action of the cephalosporins results from inhibition of cell-wall synthesis. Cefaclor has been shown to be active against most strains of the following microorganisms, both in vitro and in clinical infections: Gram positive aerobes - Staphylococci (including coagulase-positive, coagulase-negative, and penicillinase-producing strains), Streptococcus pneumoniae, and Streptococcus pyogenes (group A ß-hemolytic streptococci). Gram-negative aerobes - Escherichia coli, Haemophilus influenzae (including ß-lactamase-producing ampicillin-resistant strains), Klebsiella sp, and Proteus mirabilis.

Raniclor Absorption

Well absorbed after oral administration, independent of food intake.

Raniclor side effects and Toxicity

Symptoms of overdose include diarrhea, nausea, stomach upset, and vomiting.

Raniclor Patient Information

Patients should be counseled that antibacterial drugs including Ceclor should only be used to treat bacterial infections. They do not treat viral infections (e.g., the common cold). When Ceclor is prescribed to treat a bacterial infection, patients should be told that although it is common to feel better early in the course of therapy, the medication should be taken exactly as directed. Skipping doses or not completing the full course of therapy may (1) decrease the effectiveness of the immediate treatment and (2) increase the likelihood that bacteria will develop resistance and will not be treatable by Ceclor or other antibacterial drugs in the future.

Raniclor Organisms Affected

Enteric bacteria and other eubacteria